HESI PHARMACOLOGY EXAM QUESTIONS
60 QUESTIONS AND ANSWERS 2023-2024
UPDATE|NEW!!
Section 1: Pharmacokinetics & Pharmacodynamics
1. Which process describes the movement of a drug from its site of administration into the
bloodstream?
A. Distribution
B. Metabolism
C. Absorption
D. Excretion
Correct Answer: C
Rationale: Absorption is the movement of drug from site of administration into systemic
circulation. Distribution is movement to tissues; metabolism is biotransformation (usually
hepatic); excretion is removal (usually renal).
2. A drug with a narrow therapeutic index requires:
A. No monitoring
B. Routine serum drug level monitoring
C. Higher loading doses only
D. Administration with food only
Correct Answer: B
Rationale: Narrow therapeutic index drugs (e.g., digoxin, warfarin, phenytoin, lithium) have
small margins between therapeutic and toxic levels, so serum monitoring is essential.
3. Which organ is primarily responsible for drug metabolism?
A. Kidney
B. Liver
C. Lung
D. Spleen
Correct Answer: B
Rationale: The liver is the primary site of drug metabolism via cytochrome P450 enzymes.
The kidney is primarily responsible for excretion.
,4. First-pass effect primarily affects drugs administered:
A. Intravenously
B. Orally
C. Sublingually
D. Rectally
Correct Answer: B
Rationale: Orally administered drugs are absorbed into the portal circulation and pass
through the liver before reaching systemic circulation, reducing bioavailability. Sublingual and IV
routes bypass first pass.
5. A patient with renal impairment requires cautious dosing because:
A. Absorption is increased
B. Excretion of drugs is decreased
C. Metabolism is increased
D. Distribution is unaffected
Correct Answer: B
Rationale: Impaired renal function decreases clearance of renally excreted drugs, increasing
risk of toxicity. Doses often need reduction.
6. Which factor most increases the risk of drug toxicity in older adults?
A. Increased gastric motility
B. Decreased renal clearance
C. Increased serum albumin
D. Increased hepatic blood flow
Correct Answer: B
Rationale: Aging reduces renal clearance, hepatic function, and serum albumin, increasing
free drug levels and toxicity risk.
7. A loading dose is given to:
A. Maintain steady-state levels
B. Rapidly achieve therapeutic drug levels
C. Reduce side effects
D. Prolong half-life
Correct Answer: B
Rationale: A loading dose rapidly achieves therapeutic concentration; maintenance doses
sustain it.
,8. The half-life of a drug is:
A. Time to absorb half the dose
B. Time for plasma concentration to decrease by 50%
C. Time to excrete all drug
D. Time to reach peak effect
Correct Answer: B
Rationale: Half-life is the time required for plasma drug concentration to decrease by half; it
determines dosing intervals.
9. Which route has 100% bioavailability?
A. Oral
B. Intramuscular
C. Intravenous
D. Subcutaneous
Correct Answer: C
Rationale: IV administration places drug directly into systemic circulation, giving 100%
bioavailability.
10. A drug agonist is a substance that:
A. Blocks receptor activity
B. Activates a receptor to produce an effect
C. Increases drug excretion
D. Inhibits liver enzymes
Correct Answer: B
Rationale: Agonists bind and activate receptors. Antagonists block receptors without
activating them.
11. Which describes a synergistic drug interaction?
A. One drug cancels another
B. Combined effect is greater than the sum of individual effects
C. Effect equals the sum of individual effects
D. No interaction occurs
Correct Answer: B
Rationale: Synergism means the combined effect exceeds the sum of each drug's individual
effect (e.g., alcohol + benzodiazepines).
12. SATA: Which factors affect drug distribution? Select all that apply.
A. Protein binding
, B. Blood flow to tissues
C. Lipid solubility
D. Gastric pH
E. Body fat composition
Correct Answer: A, B, C, E
Rationale: Distribution is affected by protein binding, tissue perfusion, lipid solubility, and
body composition. Gastric pH primarily affects absorption, not distribution.
13. A prodrug requires:
A. No metabolism
B. Metabolic conversion to become active
C. IV administration only
D. Renal excretion before action
Correct Answer: B
Rationale: Prodrugs (e.g., valacyclovir) are inactive until metabolized into the active form.
14. Which statement about enteral administration is accurate?
A. It bypasses the GI tract
B. It includes oral, sublingual, and rectal routes
C. It is always faster than IV
D. It has 100% bioavailability
Correct Answer: B
Rationale: Enteral routes involve the GI tract, including oral, sublingual, buccal, and rectal.
Bioavailability varies.
15. The term "steady state" means:
A. Drug is fully excreted
B. Rate of administration equals rate of elimination
C. Peak toxicity is reached
D. Drug is stored in fat
Correct Answer: B
Rationale: Steady state occurs when the amount of drug entering the body equals the
amount being eliminated, typically after 4–5 half-lives.
Section 2: Medication Administration & Safety
60 QUESTIONS AND ANSWERS 2023-2024
UPDATE|NEW!!
Section 1: Pharmacokinetics & Pharmacodynamics
1. Which process describes the movement of a drug from its site of administration into the
bloodstream?
A. Distribution
B. Metabolism
C. Absorption
D. Excretion
Correct Answer: C
Rationale: Absorption is the movement of drug from site of administration into systemic
circulation. Distribution is movement to tissues; metabolism is biotransformation (usually
hepatic); excretion is removal (usually renal).
2. A drug with a narrow therapeutic index requires:
A. No monitoring
B. Routine serum drug level monitoring
C. Higher loading doses only
D. Administration with food only
Correct Answer: B
Rationale: Narrow therapeutic index drugs (e.g., digoxin, warfarin, phenytoin, lithium) have
small margins between therapeutic and toxic levels, so serum monitoring is essential.
3. Which organ is primarily responsible for drug metabolism?
A. Kidney
B. Liver
C. Lung
D. Spleen
Correct Answer: B
Rationale: The liver is the primary site of drug metabolism via cytochrome P450 enzymes.
The kidney is primarily responsible for excretion.
,4. First-pass effect primarily affects drugs administered:
A. Intravenously
B. Orally
C. Sublingually
D. Rectally
Correct Answer: B
Rationale: Orally administered drugs are absorbed into the portal circulation and pass
through the liver before reaching systemic circulation, reducing bioavailability. Sublingual and IV
routes bypass first pass.
5. A patient with renal impairment requires cautious dosing because:
A. Absorption is increased
B. Excretion of drugs is decreased
C. Metabolism is increased
D. Distribution is unaffected
Correct Answer: B
Rationale: Impaired renal function decreases clearance of renally excreted drugs, increasing
risk of toxicity. Doses often need reduction.
6. Which factor most increases the risk of drug toxicity in older adults?
A. Increased gastric motility
B. Decreased renal clearance
C. Increased serum albumin
D. Increased hepatic blood flow
Correct Answer: B
Rationale: Aging reduces renal clearance, hepatic function, and serum albumin, increasing
free drug levels and toxicity risk.
7. A loading dose is given to:
A. Maintain steady-state levels
B. Rapidly achieve therapeutic drug levels
C. Reduce side effects
D. Prolong half-life
Correct Answer: B
Rationale: A loading dose rapidly achieves therapeutic concentration; maintenance doses
sustain it.
,8. The half-life of a drug is:
A. Time to absorb half the dose
B. Time for plasma concentration to decrease by 50%
C. Time to excrete all drug
D. Time to reach peak effect
Correct Answer: B
Rationale: Half-life is the time required for plasma drug concentration to decrease by half; it
determines dosing intervals.
9. Which route has 100% bioavailability?
A. Oral
B. Intramuscular
C. Intravenous
D. Subcutaneous
Correct Answer: C
Rationale: IV administration places drug directly into systemic circulation, giving 100%
bioavailability.
10. A drug agonist is a substance that:
A. Blocks receptor activity
B. Activates a receptor to produce an effect
C. Increases drug excretion
D. Inhibits liver enzymes
Correct Answer: B
Rationale: Agonists bind and activate receptors. Antagonists block receptors without
activating them.
11. Which describes a synergistic drug interaction?
A. One drug cancels another
B. Combined effect is greater than the sum of individual effects
C. Effect equals the sum of individual effects
D. No interaction occurs
Correct Answer: B
Rationale: Synergism means the combined effect exceeds the sum of each drug's individual
effect (e.g., alcohol + benzodiazepines).
12. SATA: Which factors affect drug distribution? Select all that apply.
A. Protein binding
, B. Blood flow to tissues
C. Lipid solubility
D. Gastric pH
E. Body fat composition
Correct Answer: A, B, C, E
Rationale: Distribution is affected by protein binding, tissue perfusion, lipid solubility, and
body composition. Gastric pH primarily affects absorption, not distribution.
13. A prodrug requires:
A. No metabolism
B. Metabolic conversion to become active
C. IV administration only
D. Renal excretion before action
Correct Answer: B
Rationale: Prodrugs (e.g., valacyclovir) are inactive until metabolized into the active form.
14. Which statement about enteral administration is accurate?
A. It bypasses the GI tract
B. It includes oral, sublingual, and rectal routes
C. It is always faster than IV
D. It has 100% bioavailability
Correct Answer: B
Rationale: Enteral routes involve the GI tract, including oral, sublingual, buccal, and rectal.
Bioavailability varies.
15. The term "steady state" means:
A. Drug is fully excreted
B. Rate of administration equals rate of elimination
C. Peak toxicity is reached
D. Drug is stored in fat
Correct Answer: B
Rationale: Steady state occurs when the amount of drug entering the body equals the
amount being eliminated, typically after 4–5 half-lives.
Section 2: Medication Administration & Safety
